Elo Mutual Pension Insurance Co Buys 60,818 Shares of Kenvue Inc. $KVUE

Elo Mutual Pension Insurance Co boosted its stake in Kenvue Inc. (NYSE:KVUE) by 28.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 273,599 shares of the company’s stock after purchasing an additional 60,818 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Kenvue were worth $4,441,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Norges Bank bought a new position in Kenvue in the 2nd quarter valued at about $537,418,000. Independent Franchise Partners LLP lifted its holdings in shares of Kenvue by 233.4% during the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after acquiring an additional 21,886,537 shares during the period. American Century Companies Inc. boosted its position in shares of Kenvue by 38.6% during the 2nd quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock worth $633,447,000 after acquiring an additional 8,436,166 shares in the last quarter. Amundi increased its stake in Kenvue by 82.5% in the second quarter. Amundi now owns 14,509,890 shares of the company’s stock valued at $305,446,000 after acquiring an additional 6,559,261 shares during the last quarter. Finally, Mondrian Investment Partners LTD bought a new position in Kenvue in the third quarter valued at approximately $79,269,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

KVUE has been the subject of several recent analyst reports. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Canaccord Genuity Group upped their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and reduced their price objective for the company from $23.00 to $18.00 in a research note on Friday, January 30th. UBS Group lifted their target price on Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Finally, Citigroup increased their target price on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $19.50.

Kenvue Price Performance

Shares of KVUE opened at $18.17 on Wednesday. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The stock has a market cap of $34.83 billion, a PE ratio of 23.60, a PEG ratio of 4.33 and a beta of 0.51. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17. The business has a 50-day simple moving average of $17.78 and a two-hundred day simple moving average of $17.46.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $3.68 billion. During the same period in the previous year, the business posted $0.26 earnings per share. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.6%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio is 107.79%.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the company’s stock in a transaction dated Friday, December 12th. The stock was purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the purchase, the director owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.17% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.